Press Releases on May 29, 2020 - EIN Presswire - Press Release Distribution Service

Published on May 29, 2020 - 12:00 GMT

Champignon Announces Voluntary Share Lock-Up; Retains Gold Standard Media, LLC for Financial Marketing Services

VANCOUVER, British Columbia, May 29, 2020 (GLOBE NEWSWIRE) -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, today …

Distribution channels: Food & Beverage Industry, Media, Advertising & PR

Published on May 29, 2020 - 12:00 GMT

Bio-Path Holdings Presents at 2020 American Society of Clinical Oncology Annual Meeting

HOUSTON, May 29, 2020 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on May 29, 2020 - 12:00 GMT

eFFECTOR’s Tomivosertib Demonstrates Positive Phase 2 Results for Subjects with Non-Small Cell Lung Cancer in Combination with ...

Addition of Tomivosertib Conferred Benefit in Subjects Progressing on Checkpoint Inhibitors Alone Data presented at the American Society for Clinical Oncology 2020 Virtual Scientific Program SAN DIEGO, May 29, 2020 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics …

Distribution channels: Media, Advertising & PR, Technology ...

Published on May 29, 2020 - 12:00 GMT

SARS-CoV-2 was spreading in the United States in late December 2019 and may have killed over 440 patients in California and 980 ...

SEATTLE, May 29, 2020 (GLOBE NEWSWIRE) -- Dr. Steven Quay, MD, PhD, physician-scientist and CEO of Atossa Therapeutics, Inc. announced today that he and Dr. Martin Lee, PhD, Adjunct Professor of Statistics, UCLA Fielding School of Public Health, UCLA, Los …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR

Published on May 29, 2020 - 12:00 GMT

New Data Confirms Doctors' Fear: Majority of Americans Avoiding Treatment for Heart Attack and Stroke Due to COVID-19

WASHINGTON, May 29, 2020 (GLOBE NEWSWIRE) -- As states begin to re-open, 40 percent of Americans still view going to the hospital as a risky behavior – even more than going to the hair salon, a concert or the beach, according to a new national survey …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 29, 2020 - 12:00 GMT

Galera Therapeutics Announces Avasopasem Manganese Improved Markers of Chronic Kidney Disease in Patients Receiving Cisplatin

MALVERN, Penn., May 29, 2020 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on May 29, 2020 - 12:00 GMT

electroCore, Inc. to Present at Little Grapevine’s G1 Microcap Virtual Conference

BASKING RIDGE, N.J., May 29, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that that a prerecorded virtual presentation featuring Dan Goldberger, Chief Executive Officer, will …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on May 29, 2020 - 12:00 GMT

RAPT Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology Virtual Scientific Program

SOUTH SAN FRANCISCO, Calif., May 29, 2020 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for …

Distribution channels: Media, Advertising & PR, Technology ...

Published on May 29, 2020 - 12:00 GMT

Harpoon Therapeutics Presents Interim Phase 1 Data from an Ongoing Dose Escalation Trial for the PSMA-targeting TriTAC® HPN424 at ...

The on-going dose escalation Phase 1 study has enrolled 44 patients with progressive, metastatic castration-resistant prostate cancer in 11 cohorts. Initial safety data showed that HPN424 is generally well-tolerated, and cytokine-related adverse events …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on May 29, 2020 - 12:00 GMT

IGNITE Announces Acquisition of Ignite Distribution, Inc., Announces Name of New CFO, Provides Update on Annual Filings and ...

VAUGHAN, Ontario, May 29, 2020 (GLOBE NEWSWIRE) -- IGNITE International Brands, Ltd. (CSE:BILZ, OTCQX: BILZF) (“IGNITE” or the “Company”), a global consumer packaged goods brand, is pleased to announce today that it has entered into a binding term sheet, …

Distribution channels:

Published on May 29, 2020 - 12:00 GMT

HEALTH ORGANIZATIONS CHALLENGE JUUL AND RONA AMBROSE TO BAN FLAVOURS AND REDUCE NICOTINE CONTENT IN ALL OF ITS VAPING PRODUCTS

Canada, May 29, 2020 (GLOBE NEWSWIRE) -- Ottawa, Toronto, Montreal, Edmonton - Nicotine giant Juul and its latest board member—former Canadian Health Minister Rona Ambrose—are being challenged to extend new restrictions on vaping products in Nova Scotia to …

Distribution channels: Media, Advertising & PR

Published on May 29, 2020 - 12:00 GMT

BeiGene Presents Updated Head to Head Results from Phase 3 Trial of Zanubrutinib vs. Ibrutinib in Patients with Waldenström’s ...

- Additional follow-up in Phase 3 ASPEN trial continued to show clinically meaningful safety and tolerability advantages for zanubrutinib compared to ibrutinib and demonstrated favorable CR/VGPR rate - Three-year data from Phase 1/2 trial evaluating …

Distribution channels: Media, Advertising & PR, Technology ...

Published on May 29, 2020 - 12:00 GMT

Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics

- Shares of combined company to commence trading on Nasdaq Global Market under the symbol “LRMR” on May 29, 2020 - Company signed $80 million in private placement financing with biotechnology focused institutional investors - New Board Chair, Chief Medical …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on May 29, 2020 - 12:00 GMT

Syapse Announces Research Using Real-World Evidence at ASCO20 Virtual

SAN FRANCISCO, May 29, 2020 (GLOBE NEWSWIRE) -- Syapse today announced multiple research abstracts based on real-world data at the ASCO20 Virtual Annual Meeting. Syapse pairs holistic clinical information, gathered from direct integrations with our health …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on May 29, 2020 - 12:00 GMT

Allogene Therapeutics, with Collaborator Servier, Reports Positive Results from its Phase 1 ALPHA Study of ALLO-501 in Relapsed/...

ALLO-501 with ALLO-647 Lymphodepletion was Well Tolerated with No Dose-Limiting Toxicities, Graft-vs-Host Disease or Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) In the Ongoing Study, 22 Patients were Evaluable for Safety and 19 Patients …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on May 29, 2020 - 12:00 GMT

Verizon to redeem debt securities on June 29, 2020

NEW YORK, May 29, 2020 (GLOBE NEWSWIRE) -- Verizon Communications Inc. (“Verizon”) (NYSE, NASDAQ: VZ) today announced that it will redeem the following notes on June 29, 2020 (the “Redemption Date”): I.D. Number Title of Security Principal Amount …

Distribution channels: Banking, Finance & Investment Industry, Telecommunications ...

Published on May 29, 2020 - 12:00 GMT

Defense Innovation Unit Selects Zscaler for Secure Cloud Management Project

SAN JOSE, Calif., May 29, 2020 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced that the Defense Innovation Unit (DIU), a U.S. Department of Defense (DoD) organization, selected Zscaler to deliver a secure cloud …

Distribution channels: IT Industry, Media, Advertising & PR ...

Published on May 29, 2020 - 12:00 GMT

Athenex Presents Interim Data from Oral Paclitaxel Phase II Study in Cutaneous Angiosarcoma at ASCO20 Virtual Scientific Program

BUFFALO, N.Y., May 29, 2020 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer, today presented interim data …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on May 29, 2020 - 12:00 GMT

Ziopharm Oncology Presents Encouraging Clinical Data for Controlled IL-12 for the Treatment of Recurrent Glioblastoma at the 2020 ...

– Longer term follow-up from Controlled IL-12 monotherapy studies reinforces encouraging median overall survival and favorable safety profile – – Controlled IL-12 in combination with PD-1 inhibitor has favorable safety profile and initial survival data …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on May 29, 2020 - 12:00 GMT

Candente Gold Advances new Growth Strategy

VANCOUVER, British Columbia, May 29, 2020 (GLOBE NEWSWIRE) -- Candente Gold Corp. (TSXV:CDG) ("Candente Gold” and/or the “Company”) is pleased to advise that the Company is continuing to use the current slowdown in field activities in Mexico to …

Distribution channels: Media, Advertising & PR, Mining Industry ...